SUPPLEMENTATION WITH BETA GLUCAN AND ADAPTATIVE RESPONSE.
NCT ID: NCT06545149
Last Updated: 2024-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
44 participants
INTERVENTIONAL
2024-10-31
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ability of Beta-glucan Supplementation to Augment Immune Function
NCT03769012
Beta-glucans for Hospitalised Patients With COVID-19
NCT05465798
Ability of a Euglena Beta Glucan Supplementation to Augment Immune Function
NCT03518281
Researching Economical Adjuvants to Cancer Therapy
NCT07305259
A Clinical Study to Determine if Beta Glucan Reduces the Incidence, Duration or Severity of URTIs Among Skiers
NCT05917015
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
The group will receive the intervention with coconut wheat
BioNutri AR-1,
intervention with fermented and nutritionally balanced food twice a day
BioNutri AR-1
The group will receive the intervention with fermented and nutritionally balanced food
BioNutri AR-1,
intervention with fermented and nutritionally balanced food twice a day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BioNutri AR-1,
intervention with fermented and nutritionally balanced food twice a day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kaiser Clinic and Hospital
OTHER
Federal University of São Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
FERNANDO SABIA TALLO
Clinical Professor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
73701723.8.0000.0281
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.